INTERCEPT PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q1 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2012 to Q1 2023.
  • Intercept Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $89K, a 73.9% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2022 was $592K, a 79% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2021 was $2.81M, a 4.38% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2020 was $2.94M, a 19.7% decline from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $89K -$252K -73.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q1 2022 $341K -$529K -60.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q1 2021 $870K +$106K +13.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $764K -$232K -23.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $996K -$294K -22.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $1.29M +$488K +60.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $802K +$118K +17.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $684K +$434K +174% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $250K +$188K +305% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $61.7K +$39K +172% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $22.7K -$51.7K -69.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 $74.4K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.